- Home
- UHG vs SMTI Comparison
UHG vs SMTI Comparison
Compare UHG & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHG
- SMTI
- Stock Information
- Founded
- UHG 2004
- SMTI 1982
- Country
- UHG United States
- SMTI United States
- Employees
- UHG N/A
- SMTI N/A
- Industry
- UHG Homebuilding
- SMTI Medical/Dental Instruments
- Sector
- UHG Consumer Discretionary
- SMTI Health Care
- Exchange
- UHG Nasdaq
- SMTI Nasdaq
- Market Cap
- UHG 253.1M
- SMTI 288.2M
- IPO Year
- UHG N/A
- SMTI N/A
- Fundamental
- Price
- UHG $4.33
- SMTI $33.50
- Analyst Decision
- UHG
- SMTI Strong Buy
- Analyst Count
- UHG 0
- SMTI 2
- Target Price
- UHG N/A
- SMTI $47.00
- AVG Volume (30 Days)
- UHG 84.5K
- SMTI 31.5K
- Earning Date
- UHG 11-08-2024
- SMTI 11-12-2024
- Dividend Yield
- UHG N/A
- SMTI N/A
- EPS Growth
- UHG N/A
- SMTI N/A
- EPS
- UHG N/A
- SMTI N/A
- Revenue
- UHG $445,729,916.00
- SMTI $78,056,873.00
- Revenue This Year
- UHG N/A
- SMTI $29.95
- Revenue Next Year
- UHG N/A
- SMTI $19.68
- P/E Ratio
- UHG N/A
- SMTI N/A
- Revenue Growth
- UHG 6.19
- SMTI 24.66
- 52 Week Low
- UHG $4.01
- SMTI $26.00
- 52 Week High
- UHG $9.48
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- UHG 37.52
- SMTI 44.48
- Support Level
- UHG $4.01
- SMTI $31.13
- Resistance Level
- UHG $4.57
- SMTI $35.13
- Average True Range (ATR)
- UHG 0.34
- SMTI 1.80
- MACD
- UHG 0.00
- SMTI -0.16
- Stochastic Oscillator
- UHG 33.68
- SMTI 37.21
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.